Allarity Therapeutics (ALLR)
1.37
-0.05 (3.52%)
Upcoming Events
Latest Headlines
Form 8-K Allarity Therapeutics, For: Apr 17
April 18, 2024 7:01 AM - SEC Filing
Allarity Therapeutics (ALLR) Announces 5M Share Offering at $2/sh
April 17, 2024 9:19 AM - StreetInsider
Form S-1/A Allarity Therapeutics,
April 17, 2024 9:17 AM - SEC Filing
Allarity Therapeutics (ALLR) Granted Nasdaq Extension to Regain Compliance
April 17, 2024 9:10 AM - StreetInsider
Allarity Therapeutics Receives NASDAQ-Approved Extension to Regain Compliance with Nasdaq Listing Rule 5550(b)(1)
April 17, 2024 9:10 AM - StreetInsider
Form 424B5 Allarity Therapeutics,
April 15, 2024 8:30 AM - SEC Filing
Form 424B5 Allarity Therapeutics,
April 12, 2024 2:11 PM - SEC Filing
Form 424B5 Allarity Therapeutics,
April 11, 2024 1:30 PM - SEC Filing
Form 424B5 Allarity Therapeutics,
April 9, 2024 9:15 AM - SEC Filing
Form S-1/A Allarity Therapeutics,
April 8, 2024 6:02 AM - SEC Filing
Form 8-K Allarity Therapeutics, For: Apr 04
April 5, 2024 8:30 AM - SEC Filing
Form 8-K Allarity Therapeutics, For: Apr 01
April 4, 2024 5:02 PM - SEC Filing
Allarity Therapeutics (ALLR) Announces 1:20 Reverse Share Split
April 4, 2024 9:15 AM - StreetInsider
Allarity Therapeutics Announces 1-for-20 Reverse Stock Split
April 4, 2024 9:15 AM - StreetInsider
Form 8-K Allarity Therapeutics, For: Mar 27
April 1, 2024 9:37 AM - SEC Filing
Allarity Therapeutics (ALLR) to Focus Solely on Accelerating Stenoparib Toward Regulatory Approval
March 27, 2024 8:32 AM - StreetInsider
Allarity Therapeutics Makes Strategic Pivot to Focus Solely on Accelerating Stenoparib Toward Regulatory Approval in Advanced Recurrent Ovarian Cancer
March 27, 2024 8:30 AM - StreetInsider
Form 8-K Allarity Therapeutics, For: Mar 25
March 26, 2024 8:06 AM - SEC Filing
Form S-8 Allarity Therapeutics,
March 25, 2024 4:34 PM - SEC Filing
Allarity Therapeutics (ALLR) Receives Nasdaq Extension to Regain Compliance
March 25, 2024 7:32 AM - StreetInsider
Allarity Therapeutics Receives Extension from Nasdaq Hearings Panel to Regain Compliance with Listing Rules 5550(a)(2) and 5550(b)(1)
March 25, 2024 7:30 AM - StreetInsider
Allarity Therapeutics (ALLR) Enters ATM Agreement
March 20, 2024 6:08 AM - StreetInsider
Form 8-K Allarity Therapeutics, For: Mar 19
March 20, 2024 6:02 AM - SEC Filing
Form 424B5 Allarity Therapeutics,
March 20, 2024 6:02 AM - SEC Filing
Form 8-K Allarity Therapeutics, For: Mar 14
March 15, 2024 9:15 AM - SEC Filing
Form 8-K Allarity Therapeutics, For: Mar 08
March 8, 2024 8:39 AM - SEC Filing
Form 10-K Allarity Therapeutics, For: Dec 31
March 8, 2024 7:17 AM - SEC Filing
Allarity Therapeutics Reports Full Year 2023 Financial Results and Provides a Business Update
March 8, 2024 7:15 AM - StreetInsider
Form DEF 14A Allarity Therapeutics, For: Apr 01
March 8, 2024 6:04 AM - SEC Filing
Form 8-K Allarity Therapeutics, For: Feb 28
March 4, 2024 4:06 PM - SEC Filing
Form 8-K Allarity Therapeutics, For: Feb 27
March 1, 2024 9:21 AM - SEC Filing
Allarity Therapeutics to Present at Biomarkers 2024
February 28, 2024 6:00 AM - StreetInsider
Form PRER14A Allarity Therapeutics,
February 23, 2024 4:11 PM - SEC Filing
Form 8-K Allarity Therapeutics, For: Feb 13
February 14, 2024 9:03 AM - SEC Filing
Form SC 13G/A Allarity Therapeutics, Filed by: 3i, LP
February 12, 2024 9:52 AM - SEC Filing
Form D Allarity Therapeutics,
February 2, 2024 5:04 PM - SEC Filing
Form 8-K Allarity Therapeutics, For: Jan 26
February 1, 2024 4:40 PM - SEC Filing
Form PRE 14A Allarity Therapeutics, For: Jan 26
January 26, 2024 5:08 PM - SEC Filing
Full Article List
